Provided by Tiger Trade Technology Pte. Ltd.

ZAI LAB

20.240
-0.780-3.71%
Volume:3.44M
Turnover:69.67M
Market Cap:25.46B
PE:-126.29
High:20.820
Open:20.820
Low:20.020
Close:21.020
52wk High:21.500
52wk Low:12.310
Shares:1.26B
HK Float Shares:1.26B
Volume Ratio:0.53
T/O Rate:0.27%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-0.160
ROE:-29.99%
ROA:-15.93%
PB:5.76
PE(LYR):-126.29
PS:7.35

Loading ...

HK Movers | Biotech Shares Advance; BEONE MEDICINES Up Over 6%

Tiger Newspress
·
Nov 04

Zai Lab Raises Share Capital by 9.97% Through Private Placement of 113.40 Million New Shares

Bulletin Express
·
Oct 28

Zai Lab Reports 113,400,000 New Shares in HKEX Next-Day Disclosure Return

Reuters
·
Oct 28

Zai Lab Completes USD 249.93 Million Private Placement of 11.34 Million ADSs, Expanding Public Float to 95.16%

Bulletin Express
·
Oct 28

Zai Lab Closes USD 249.93 Million Private Placement of ADSs

Reuters
·
Oct 28

Zai Lab's Zoci Earns Strong Backing as a Potential Backbone Therapy, Continues to Expand Its Future Value Horizon

Stock News
·
Oct 27

Hong Kong Stocks Close Higher as Oil Shares Shine, AI Hardware and Metals Retreat

Stock News
·
Oct 26

Zai Lab's Lung Cancer Drug Achieves Promising Response Rate in Phase 1b Trial; Shares up 4%

MT Newswires Live
·
Oct 26

Zai Lab Shares Surge Over 7% Intraday as Zoci Plus Atezolizumab First-Line ES-SCLC Data Debuts at ESMO

Deep News
·
Oct 26

Zai Lab Stock Rises Over 2% as Early-Stage Data for Investigational ADC Zoci Shows Promise

Stock News
·
Oct 23

Zai Lab to Review and Release Q3 2026 Financial Results on 5 November

Bulletin Express
·
Oct 23

Zai Lab Plans to Host Q3 Earnings Call and Webcast

Reuters
·
Oct 23

Zai Lab’s Zoci Combination Achieves 81.8% Response Rate in First-Line Lung Cancer Trial

Reuters
·
Oct 23

Zai Lab’s Zocilurtatug Pelitecan (Zoci, Formerly Zl-1310) Demonstrates High Response Rates, Encouraging Durability and Well-Tolerated Safety Profile in First-Line Extensive-Stage Small Cell Lung Cancer

THOMSON REUTERS
·
Oct 23

Zai Lab Agrees to Issue to Investors Aggregate of 11.3 Million ADSs

Reuters
·
Oct 23

Zai Lab Announces $250 Million Private Placement

THOMSON REUTERS
·
Oct 23

Zai Lab Ltd - Agreed to Issue & Sell to Investors Aggregate of 11.3 Mln Adss at US$22.04/Ads

THOMSON REUTERS
·
Oct 23

Zai Lab Agrees to USD 249.93 Million Private Placement

Reuters
·
Oct 23

Hong Kong Stock Connect Innovative Drug Sector Plunges Sharply as Index Drops Over 4.6%, Zai Lab and Akeso Suffer Major Losses

Deep News
·
Oct 22

Zai Lab Sets Third-Quarter 2026 Financial Results Release

Reuters
·
Oct 21